JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

JNJ

224.16

-1.45%↓

UNH

370.76

+0.47%↑

TMO

462.35

-1.48%↓

ISRG

452.39

-1.14%↓

ABT

87.56

-2.18%↓

Kodu・Aktsiate loetelu・NeoGenomics Inc

NeoGenomics Inc

Suletud

8.99 -4.87

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

8.99

Max

9.65

Põhinäitajad
By Trading Economics
Sissetulek	17M -9.9M
Müük	2.4M 190M
Kasumimarginaal	-5.196
Töötajad	2,500
EBITDA	15M 5.3M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+58.26% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	28. juuli 2026

Turustatistika
By TradingEconomics
Turukapital	-352M 1.1B
Eelmine avamishind	13.86
Eelmine sulgemishind	8.99

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

7.7 / 10.27 Toetus ja vastupanu

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. mai 2026, 18:18 UTC

Market Talk

Bitcoin Pushes Over $80k as Oil-BTC Relationship Steps Aside -- Market Talk

4. mai 2026, 14:38 UTC

Market Talk

Bitcoin Stuck Between Narratives -- Market Talk

4. mai 2026, 14:21 UTC

Market Talk

Bitcoin Below $80k Resistance -- Market Talk

1. mai 2026, 19:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. mai 2026, 19:33 UTC

Market Talk

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1. mai 2026, 17:37 UTC

Market Talk

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1. mai 2026, 16:38 UTC

Market Talk

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1. mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1. mai 2026, 15:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. mai 2026, 15:43 UTC

Market Talk

Correlation Between Bitcoin and Equities Seen Loosening -- Market Talk

1. mai 2026, 15:43 UTC

Market Talk

Global Equities Roundup: Market Talk

1. mai 2026, 11:40 UTC

Market Talk

Bitcoin Rises as U.S. Stock Futures Point to Further Gains -- Market Talk

1. mai 2026, 07:09 UTC

Market Talk

Tulu

Bitcoin Rises After Gains on Wall Street -- Market Talk

30. apr 2026, 18:00 UTC

Market Talk

Cryptocurrency Rebounds After Fed Holds Rates Steady -- Market Talk

30. apr 2026, 13:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30. apr 2026, 13:47 UTC

Market Talk

Bitcoin Rises But Iran War Uncertainty Keeps Gains Limited -- Market Talk

30. apr 2026, 07:02 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

30. apr 2026, 07:02 UTC

Market Talk

Tulu

Global Energy Roundup: Market Talk

30. apr 2026, 07:02 UTC

Market Talk

Tulu

Bitcoin Recovers Slightly as Trades Weigh Tech Earnings, Iran War News -- Market Talk

29. apr 2026, 18:15 UTC

Market Talk

Cryptocurrency Down Following Fed Decision -- Market Talk

29. apr 2026, 17:25 UTC

Tulu

Robinhood Stock Falls After Earnings Fall Short. Blame the Crypto Slump. -- Barrons.com

29. apr 2026, 13:58 UTC

Market Talk

Cryptocurrencies Turn Higher as Market Awaits Fed -- Market Talk

29. apr 2026, 11:18 UTC

Market Talk

Bitcoin Rises Modestly as U.S. Stock Futures Rise -- Market Talk

29. apr 2026, 09:32 UTC

Tulu

Robinhood Stock Falls After Earnings Fall Short. Blame the Crypto Slump. -- Barrons.com

29. apr 2026, 07:22 UTC

Market Talk

Uudisväärsed sündmused

Global Energy Roundup: Market Talk

29. apr 2026, 07:22 UTC

Market Talk

Uudisväärsed sündmused

Bitcoin Edges Higher But Iran War Uncertainties Limit Gains -- Market Talk

28. apr 2026, 22:51 UTC

Tulu

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28. apr 2026, 20:51 UTC

Tulu

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28. apr 2026, 20:24 UTC

Tulu

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28. apr 2026, 17:24 UTC

Market Talk

Bitcoin Stabilizes Around $76k After ETF Inflow Streak Ends -- Market Talk

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

58.26% tõus

12 kuu keskmine prognoos

Keskmine 14.94 USD 58.26%

Kõrge 25 USD

Madal 11 USD

Põhineb 12 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

Osta

Hoia

Müü

Põhineb 12 analüütiku instrumendi NeoGenomics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

7.7 / 10.27Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.